Hemostatic efficacy of a fibrin sealant dressing in an animal model of kidney injury

被引:32
作者
Jackson, MR
Taher, MM
Burge, JR
Krishnamurti, C
Reid, TJ
Alving, BM
机构
[1] Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75235 USA
[2] Walter Reed Army Inst Res, Washington, DC USA
[3] Washington Hosp Ctr, Washington, DC 20010 USA
关键词
fibrin sealant; fibrin glue; hemostasis; bleeding;
D O I
10.1097/00005373-199810000-00003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The purpose of this study is to determine the hemostatic efficacy of a fibrin sealant dressing compared with a standard collagen control dressing in an animal model of kidney injury. Methods: Twenty adult male Sprague-Dawley rats were administered general anesthesia and underwent partial nephrectomy with heparin anticoagulation (300 U/kg intravenous). Treatment of the cut surface of the kidney was randomized to three groups: group I, no hemostatic agent; group II, collagen dressing; and group III, fibrin sealant dressing. Results: Blood loss was significantly less in group III (3.39 +/- 0.63 mL) than in group I (8.64 +/- 2.26 mL) and group II (8.63 +/- 1.72 mL; p < 0.001). The percentage decrease in the mean arterial pressure was significantly less in group III (34.09 a 15.58%) than in group I (59.66 +/- 16.19%) and group II (60.35 +/- 15.66%; p = 0.015), Conclusion: Fibrin sealant dressings provide effective hemostasis and are superior to collagen dressings in an animal model of kidney injury. Additional development of fibrin sealant dressings for potential clinical use is warranted.
引用
收藏
页码:662 / 665
页数:4
相关论文
共 22 条
[11]   4 YEARS EXPERIENCE WITH FIBRIN SEALANT IN THORACIC AND CARDIOVASCULAR-SURGERY [J].
MATTHEW, TL ;
SPOTNITZ, WD ;
KRON, IL ;
DANIEL, TM ;
TRIBBLE, CG ;
NOLAN, SP .
ANNALS OF THORACIC SURGERY, 1990, 50 (01) :40-44
[12]   FIBRIN SEALANT REDUCES SUTURE LINE BLEEDING DURING CAROTID ENDARTERECTOMY - A RANDOMIZED TRIAL [J].
MILNE, AA ;
MURPHY, WG ;
READING, SJ ;
RUCKLEY, CV .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 10 (01) :91-94
[13]  
MORGENSTERN L, 1974, ARCH SURG-CHICAGO, V109, P44
[14]   CRYOPRECIPITATE AS A RELIABLE SOURCE OF FIBRINOGEN REPLACEMENT [J].
NESS, PM ;
PERKINS, HA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (16) :1690-1691
[15]  
NICHOLS WL, 1993, BLOOD, V82, P59
[16]   FIBRIN GLUE AS A HEMOSTATIC AGENT IN HEPATIC AND SPLENIC TRAUMA [J].
OCHSNER, MG ;
MANISCALCOTHEBERGE, ME ;
CHAMPION, HR .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1990, 30 (07) :884-887
[17]   COMPARATIVE EFFICACY OF TOPICAL HEMOSTATIC AGENTS IN A RAT-KIDNEY MODEL [J].
RACCUIA, JS ;
SIMONIAN, G ;
DARDIK, M ;
HALLAC, D ;
RACCUIA, SV ;
STAHL, R ;
DARDIK, H .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (02) :234-238
[18]  
ROUSOU J, 1989, J THORAC CARDIOV SUR, V97, P194
[19]  
SCHEELE J, 1984, SURGERY, V95, P6
[20]   REDUCTION OF PERIOPERATIVE HEMORRHAGE BY ANTERIOR MEDIASTINAL SPRAY APPLICATION OF FIBRIN GLUE DURING CARDIAC OPERATIONS [J].
SPOTNITZ, WD ;
DALTON, MS ;
BAKER, JW ;
NOLAN, SP .
ANNALS OF THORACIC SURGERY, 1987, 44 (05) :529-531